Latest News

Billionaire Israel Englander Pulls the Trigger on These 2 “Strong Buy” Stocks


Insider Monkey

Should You Consider Investing in NIO?

Horos Asset Management, an investment management firm, published its first-quarter 2022 investor letter – a copy of which can be downloaded here. Since the inception of Horos (May 21, 2018), Horos Value Internacional has returned 22.3%, below the 55.2% gain of its benchmark, while Horos Value Iberia has returned 8.1%, outperforming the 0.5% return of […]

Biotech Stock News: Kiora Pharmaceuticals (NASDAQ: KPRX) Receives Clinical Trial Approval for First-in-Human Evaluation of KIO-301 to Restore Vision in Patients with Retinitis Pigmentosa

Previous article

Nanotechnology Stock News: SureNano Science (CSE: SURE) Signs Licensing Agreement for the State of Oklahoma

Next article

You may also like


Leave a reply

Your email address will not be published.

More in Latest News